Patents Assigned to Manus Pharmaceuticals (Canada) Ltd.
  • Peptide-based compounds and uses thereof to treat beta-amyloid accumulation
    Patent number: 9718869
    Abstract: The present application relates to novel peptide-based compounds, optionally comprising an immunoactive built-in adjuvant, compositions comprising these compounds and their use, in particular for the treatment of diseases, disorders or conditions characterized by or associated with ?-amyloid accumulation. In particular, the present application includes compounds of Formula I, and compositions and uses thereof: [Ra-NP]m-Lp (I).
    Type: Grant
    Filed: July 24, 2013
    Date of Patent: August 1, 2017
    Assignee: MANUS PHARMACEUTICALS (CANADA) LTD.
    Inventors: Vladislav Deigin, Olga Volpina, Natalia Bobkova
  • Substituted piperazin-2,5-diones as multifunctional bioactive compounds
    Patent number: 9108931
    Abstract: The invention relates to novel multifunctional bioactive compounds of the formula I: pharmaceutical compositions comprising these compounds and methods of using these compounds, in particular as therapeutic agents for the treatment of immune disorders.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: August 18, 2015
    Assignee: MANUS PHARMACEUTICALS (CANADA) LTD.
    Inventor: Vladislav I. Deigin
  • MULTIFUNCTIONAL BIOACTIVE COMPOUNDS
    Publication number: 20140179708
    Abstract: The invention relates to novel multifunctional bioactive compounds, pharmaceutical compositions comprising these compounds and methods of using these compounds, in particular as therapeutic agents.
    Type: Application
    Filed: December 19, 2013
    Publication date: June 26, 2014
    Applicant: Manus Pharmaceuticals (Canada) Ltd.
    Inventor: Vladislav I. Deigin
  • Substituted piperazin-2,5-diones and their use as multifunctional bioactive compounds
    Patent number: 8637521
    Abstract: The present invention discloses multifunctional bioactive compounds of formula (I) constituted of an immunoregulatory portion linked to a stabilizer moiety and pharmaceutical compositions thereof useful in the treatment of immune disorders and hemopoietic disorders such as immune cytopema, multiple myeloma, chronic lymphoid leucosis, lymphocytic lymphomas, lymphosarcomas.
    Type: Grant
    Filed: August 1, 2007
    Date of Patent: January 28, 2014
    Assignee: Manus Pharmaceuticals (Canada) Ltd.
    Inventor: Vladislav I. Deigin